Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Shares Outstanding (Diluted Average) (2024 - 2026)

Carlsmed filings provide 2 years of Shares Outstanding (Diluted Average) readings, the most recent being $14.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 249.74% to $14.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.2 million, a 249.74% increase, with the full-year FY2025 number at $14.2 million, up 249.74% from a year prior.
  • Shares Outstanding (Diluted Average) hit $14.2 million in Q4 2025 for Carlsmed, up from $10.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $14.2 million in Q4 2025 to a low of $4.0 million in Q3 2024.